Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
NADMED logo

NADMED

Recent Finacing

Series A

Recent Raise

$3.9M

Nadmed is a Helsinki biotech company providing a rapid colorimetric assay quantifying all four NADs and glutathione forms from minimal fresh blood, compatible with clinical labs, research institutions and pharma.

Founded 2022
Southern Finland, Finland
11-50
Private
nadmed.com

Highlights

Focus Areas

Biotechnology
Product Research

Recent Investors

University of Helsinki Funds logo
Business Finland logo
Voima Ventures logo
Nordic Science Investments logo

Financials

$3.9M

Total Raised

1

Funding round

4

Investors